Health Technology Assessment: Definition, History and Outcome. What Is the Responsibility of ISR in This Field?

Definition: New instrumental medical interventions"nlead to new financial problems and some questions"nmust be answered for service receivers and insurance"ncompanies (payers) and scientific, academic and"ngovernmental societies and organs about the safety,"nefficiency and cost of these new procedures."nHistory: 1967 - Technology Assessment first used"nin the Subcommittee on Science, Research, and"nDevelopment of the House Science and Astronautics"nCommittee of the U.S. Congress."n1972 - The U.S. Congress created the (The Office of"nTechnology Assessment (OTA) by Public Law 92-484."nOTA provide analysis of the complex scientific and"ntechnical issues from 1972 to 1995."n1987 - Scientific Technology Options Assessment"n(STOA)-an official organ of the European Parliament"n- started releasing reports partnering with external"nexperts."n1990 - The European Parliamentary Technology"nAssessment Network-EPTA was formally established"nunder the patronage of the President of the European"nParliament to advise parliaments on the possible social,"neconomic and environmental impact of new sciences"nand technologies. For example, working in the future,"nstructures and trends in industrial work and vaccine"ncapacity in the UK."nIn 1973-1975, roots of Health Technology were"nestablished:"nThe U.S. Academy of Sciences published a report that"nexamined the implications of four health technologies:"nin vitro fertilization, choosing the sex of children,"nretardation of aging, and modifying human behavior"nThe National Institutes of Health carried out a rather"ncomprehensive assessment of the totally implantable artificial heart in 1973."nThe Swedish Organization, Spri, carried out a costeffective"nanalysis of the computed tomography (CT)"nscanner (the first HTA outside the US)."nOutcome: Accelerated improvement in the medical"ndiagnostic field requires independent reliable medical"nand economic scientists for assessment of the costeffectiveness"nof the new procedures. They must not be"nrelated or sponsored with new solution providers and"nalso governmental organs.